Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 167


Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies.

Ess SM, Herrmann C, Bouchardy C, Neyroud I, Rapiti E, Konzelmann I, Bordoni A, Ortelli L, Rohrmann S, Frick H, Mousavi M, Thürlimann B.

Breast. 2018 Oct;41:151-158. doi: 10.1016/j.breast.2018.07.011. Epub 2018 Jul 30.


Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP; CONCORD Working Group.

Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.


Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study.

Minicozzi P, Innos K, Sánchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, Botta L, Visser O, Rossi S, Tavilla A, Sant M; EUROCARE-5 Working Group.

Eur J Cancer. 2017 Oct;84:335-353. doi: 10.1016/j.ejca.2017.07.015. Epub 2017 Sep 1.


Multiple primary tumours: challenges and approaches, a review.

Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A.

ESMO Open. 2017 May 2;2(2):e000172. doi: 10.1136/esmoopen-2017-000172. eCollection 2017. Review.


Geographical variability in survival of European children with central nervous system tumours.

Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sánchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L; EUROCARE-5 Working Group.

Eur J Cancer. 2017 Sep;82:137-148. doi: 10.1016/j.ejca.2017.05.028. Epub 2017 Jul 6.


Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 396-404].

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group.

Gynecol Oncol. 2017 Dec;147(3):725. doi: 10.1016/j.ygyno.2017.06.033. Epub 2017 Jul 5. No abstract available.


Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 405-413].

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; CONCORD Working Group; Africa.

Gynecol Oncol. 2017 Dec;147(3):726. doi: 10.1016/j.ygyno.2017.06.032. Epub 2017 Jul 5. No abstract available.


Evaluation of completeness of case ascertainment in Swiss cancer registration.

Lorez M, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Dehler S, Frick H, Konzelmann I, Maspoli M, Mousavi SM, Rohrmann S, Arndt V.

Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S139-S146. doi: 10.1097/CEJ.0000000000000380.


Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.

Ess SM, Herrmann C, Frick H, Krapf M, Cerny T, Jochum W, Früh M.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12721. Epub 2017 May 30.


Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.

Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Piñeros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C; CONCORD Working Group.

Lancet Haematol. 2017 May;4(5):e202-e217. doi: 10.1016/S2352-3026(17)30052-2. Epub 2017 Apr 11. Erratum in: Lancet Haematol. 2017 May;4(5):e201.


Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.

Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group.

Eur J Cancer. 2017 May;77:140-152. doi: 10.1016/j.ejca.2017.02.023. Epub 2017 Apr 11.


Different Patterns of Hearing Loss among Tinnitus Patients: A Latent Class Analysis of a Large Sample.

Langguth B, Landgrebe M, Schlee W, Schecklmann M, Vielsmeier V, Steffens T, Staudinger S, Frick H, Frick U.

Front Neurol. 2017 Feb 20;8:46. doi: 10.3389/fneur.2017.00046. eCollection 2017.


A randomized controlled trial demonstrating sustained benefit of Autologous Matrix-Induced Chondrogenesis over microfracture at five years.

Volz M, Schaumburger J, Frick H, Grifka J, Anders S.

Int Orthop. 2017 Apr;41(4):797-804. doi: 10.1007/s00264-016-3391-0. Epub 2017 Jan 20.


The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; & the CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):405-413. doi: 10.1016/j.ygyno.2016.10.019. Epub 2016 Dec 6. Erratum in: Gynecol Oncol. 2017 Dec;147(3):726.


Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):396-404. doi: 10.1016/j.ygyno.2016.11.019. Epub 2016 Dec 2. Erratum in: Gynecol Oncol. 2017 Dec;147(3):725.


DNA barcode data accurately assign higher spider taxa.

Coddington JA, Agnarsson I, Cheng RC, Čandek K, Driskell A, Frick H, Gregorič M, Kostanjšek R, Kropf C, Kweskin M, Lokovšek T, Pipan M, Vidergar N, Kuntner M.

PeerJ. 2016 Jul 20;4:e2201. doi: 10.7717/peerj.2201. eCollection 2016.


Aqua Cycling Does Not Affect Recovery of Performance, Damage Markers, and Sensation of Pain.

Wahl P, Sanno M, Ellenberg K, Frick H, Böhm E, Haiduck B, Goldmann JP, Achtzehn S, Brüggemann GP, Mester J, Bloch W.

J Strength Cond Res. 2017 Jan;31(1):162-170. doi: 10.1519/JSC.0000000000001462.


Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees.

Circ Heart Fail. 2016 Jan;9(1). pii: e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.


Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).

Mounier M, Bossard N, Remontet L, Belot A, Minicozzi P, De Angelis R, Capocaccia R, Iwaz J, Monnereau A, Troussard X, Sant M, Maynadié M, Giorgi R; EUROCARE-5 Working Group; CENSUR Working Survival Group.

Lancet Haematol. 2015 Nov;2(11):e481-91. doi: 10.1016/S2352-3026(15)00155-6. Epub 2015 Oct 23.


Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011.

Feller A, Fehr M, Bordoni A, Bouchardy C, Frick H, Mousavi M, Steiner A, Arndt V, Clough-Gorr KM; Nicer Working Group.

Swiss Med Wkly. 2015 Dec 10;145:w14245. doi: 10.4414/smw.2015.14245. eCollection 2015.

Supplemental Content

Loading ...
Support Center